• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 85 Day 2 on August 21; Register to live stream

    8/20/25 7:00:00 AM ET
    $ADVM
    $CLNN
    $DERM
    $EHGO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    MIAMI, Aug. 20, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1 – Presenting Today, August 20, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Immuron Limited (NASDAQ:IMRN)

    Keynote speaker: Steve Lydeamore, CEO

    9:40 – 10:10

    Nutriband, Inc. (NASDAQ:NTRB)

    Keynote speaker: Serguei Melnik, Founder and President

    10:50 – 11:20

    Metaguest.ai Inc. (OTCQB:MGSTF) (CSE:METG)

    Keynote speaker: Colin Keddy, President

    11:25 – 11:55

    Kelly+Partners (OTCQX:KPGHF) (ASX: KPG)

    Keynote speaker: Brett Kelly, Founder, Executive Chairman & CEO

    12:35 – 1:05

    Journey Medical Corporation (NASDAQ:DERM)

    Keynote speaker: Claude Maraoui - Founder, President, CEO & Director

    1:10 – 1:40

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    1:45 – 2:15

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:20 – 2:50

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 – 3:20

    HeartSciences, Inc. (NASDAQ:HSCS)

    Keynote speaker: Andrew Simpson, President / CEO

    Postponed to September 24

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    3:40 – 3:50

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    3:55 – 4:05

    BitFuFu Inc. (NASDAQ:FUFU)

    Keynote speaker: Charley Brady, VP Investor Relations

    4:10 – 4:20

    Impact Minerals Limited, (ASX: IPT)

    Keynote speaker: Dr. Mike Jones, Managing Director

    4:25 – 4:35

    Zyppah, a Private Company

    Keynote speaker: Dr. Jonathan Greenburg, founder and owner, & Larry Biggs, CEO

    4:40 – 4:50

    Ucore Rare Metals, Inc. (OTCQX:UURAF) (TSXV:UCU)

    Keynote speakers: Pat Ryan, CEO

    _______________________________________________________________

    Day 2 – Presenting Tomorrow, August 21, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Eshallgo, Inc. (NASDAQ:EHGO)

    Keynote speakers: Johnny Wu, President

    10:15 – 10:45

    Terra Clean Energy (OTCQB:TCEFF) (CSE:TCEC)

    Keynote speaker: Greg Cameron, CEO

    10:50 – 11:20

    Grove Collaborative Holdings, Inc. (NYSE:GROV)

    Keynote speakers: Jeff Yurcisin, CEO & Tom Siragusa, Interim CFO

    11:25 – 11:55

    Phoenix Energy Services Corp., (OTCQB:PHXHF) (TSE: PHX)

    Keynote speaker: Mike Buker, President and CEO

    12:00 – 12:30

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest, CEO

    12:35 – 1:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden – VP Corporate Development

    1:10 – 1:40

    Kobo Resources, Inc. (OTCQB:KBRIF) (TSXV:KRI)

    Keynote speakers: Edouard Gosselin, Director, CEO and Corporate Secretary & Paul Sarjeant, Director, President and COO

    1:45 – 2:15

    Puma Exploration Inc. (TSXV:PUMA) (OTCQB:PUMXF)

    Marcel Robillard, CEO & President

    2:20 – 2:50

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    2:55 – 3:05

    Highland Copper Company Inc. (OTCQB:HDRSF) (TSXV:HI)

    Keynote speaker: Barry O'Shea, CEO

    3:10 - 3:20

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    3:25 – 3:35

    C3 Metals Inc. (TSXV:CCCM) (OTCQB:CUAUF)

    Keynote speaker: Daniel A. Symons, President, CEO & Director

    3:40 – 3:50

    Lahontan Gold Corp. (TSXV:LG) (OTCQB:LGCXF)

    Keynote speaker: Kimberly Ann, President / CEO

    3:55 – 4:05

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    4:10 – 4:20

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    4:25 – 4:35

    Star Gold Corp. (OTCQB:SRGZ)

    Keynote speaker: Lindsay E. Gorrill, Chairman & CEO

    4:40 – 4:50

    NCS Multistage Holdings, Inc. (NASDAQ:NCSM)

    Keynote speaker: Ryan Hummer, CEO & Director

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $CLNN
    $DERM
    $EHGO

    CompanyDatePrice TargetRatingAnalyst
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    Journey Medical Corporation
    $DERM
    8/25/2025$13.00Buy
    H.C. Wainwright
    BitFuFu Inc.
    $FUFU
    8/13/2025$6.00Buy
    Roth Capital
    Journey Medical Corporation
    $DERM
    7/30/2025$12.00Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    7/18/2025Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    6/18/2025$5.50Market Perform
    Northland Capital
    Grove Collaborative Holdings Inc.
    $GROV
    5/15/2025$1.20Outperform → Market Perform
    Telsey Advisory Group
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    More analyst ratings

    $ADVM
    $CLNN
    $DERM
    $EHGO
    SEC Filings

    View All

    SEC Form 6-K filed by BitFuFu Inc.

    6-K - Bitfufu Inc. (0001921158) (Filer)

    1/7/26 8:00:27 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    SEC Form DEF 14A filed by 22nd Century Group Inc.

    DEF 14A - 22nd Century Group, Inc. (0001347858) (Filer)

    12/30/25 5:19:44 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Nutriband Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - NutriBand Inc. (0001676047) (Filer)

    12/30/25 4:28:50 PM ET
    $NTRB
    Industrial Specialties
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    H.C. Wainwright initiated coverage on Journey Medical with a new price target

    H.C. Wainwright initiated coverage of Journey Medical with a rating of Buy and set a new price target of $13.00

    8/25/25 8:12:40 AM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Roth Capital initiated coverage on BitFuFu with a new price target

    Roth Capital initiated coverage of BitFuFu with a rating of Buy and set a new price target of $6.00

    8/13/25 8:06:38 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $ADVM
    $CLNN
    $DERM
    $EHGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent bought $553,917 worth of shares (128,699 units at $4.30), increasing direct ownership by 177% to 201,513 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:06 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF OPERATING OFFICER Soparkar Peter bought $211,000 worth of shares (50,000 units at $4.22), increasing direct ownership by 166% to 80,189 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:04 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CEO Smith Ryan Lewis bought $4,560 worth of shares (4,000 units at $1.14), increasing direct ownership by 0.34% to 1,183,039 units (SEC Form 4)

    4 - US ENERGY CORP (0000101594) (Issuer)

    9/15/25 7:00:12 AM ET
    $USEG
    Oil & Gas Production
    Energy

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BitFuFu Announces December 2025 Bitcoin Production and Operational Updates

    SINGAPORE, Jan. 07, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited Bitcoin production and operational metrics for December 2025. "In 2025 we mined 3,662 BTC, reduced pledged balances, continued to build our Bitcoin treasury, and created value for cloud mining customers through reliable capacity, service and uptime. As we enter 2026, recent Bitcoin strength and our improved liquidity position reinforce our optimistic outlook for the year ahead," said Leo Lu, Chairman and CEO of BitFuFu. December 2025 Highlights (as of December 31, 2025) Bitcoin Holdings and Produ

    1/7/26 8:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    22nd Century Files VLN® MRTP Renewal – Only Combustible Tobacco Product Authorized by the FDA Specifically to Help Smokers Smoke Less

    VLN® Reduced Nicotine Content Tobacco Reduces Smoking and Increases Quit Attempts Per Clinical Data Multiple VLN® Based Cigarette Brands Expand Availability and Reach of Non-Addictive Alternative in the Fight Against The Harms of Smoking MOCKSVILLE, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 28 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced the filing of its Modified Risk Tobacco Product renewal application for its innovative VLN® reduced nicotine content products, the first and still the only combustible cigarette authorized by the U.S

    1/6/26 6:10:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Nutriband CEO Publishes Letter to Shareholders

    ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 and the potential outlook for 2026. The full text of the letter is below. Dear Shareholders, As we wrapped up a successful 2025, the entire team at Nutriband would like to extend our warmest appreciation to all of you for your continued support throughout 2025 and into 2026. I always stress and extend our appreciation to the many of you that have been with us from the beginning and now the many more who have joined our common goal along the way. This goal

    12/31/25 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Ugwumba Chidozie sold $78,011 worth of shares (12,918 units at $6.04) (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/7/26 5:28:09 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Ugwumba Chidozie sold $99,088 worth of shares (17,110 units at $5.79) (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/2/26 5:25:57 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Ugwumba Chidozie sold $73,123 worth of shares (12,234 units at $5.98) (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    12/31/25 12:10:37 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Financials

    Live finance-specific insights

    View All

    Nutriband CEO Publishes Letter to Shareholders

    ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements and milestones through 2025 and the potential outlook for 2026. The full text of the letter is below. Dear Shareholders, As we wrapped up a successful 2025, the entire team at Nutriband would like to extend our warmest appreciation to all of you for your continued support throughout 2025 and into 2026. I always stress and extend our appreciation to the many of you that have been with us from the beginning and now the many more who have joined our common goal along the way. This goal

    12/31/25 7:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care

    Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®

    FDA recommended biomarker analyses show statistically significant reductions in NfL and GFAP in participants treated with CNM-Au8Biomarker improvements are strongly associated with longer survival, reinforcing CNM-Au8's potential disease modifying activityCompany has requested a Type C meeting in the first quarter of 2026 to present the newly completed analyses supporting a planned NDA submission under the accelerated approval pathwayClene is hosting an investor webcast today at 8:30 am ET SALT LAKE CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene" or the "Company") and its wholly owned subsidiary Clene Nanomedicine, Inc., a late clinic

    12/3/25 8:00:00 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Grove Announces Third Quarter 2025 Financial Results

    Grove Collaborative Holdings, Inc. (NYSE:GROV) ("Grove" or the "Company"), the world's first plastic neutral retailer and a leading sustainable consumer products company, certified B Corporation, and Public Benefit Corporation, today reported financial results for its fiscal third quarter ended September 30, 2025. Key Financial Highlights: (comparison vs prior year unless otherwise noted) Total Revenue was $43.7 million, down 9.4% year-over-year; down 0.7% versus Q2 Net Loss of $3.0 million, compared to Net Loss of $1.3 million in same period last year Adjusted EBITDA loss of $1.2 million, compared to breakeven in same period last year Executed a reduction in force in November

    11/13/25 4:10:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Journey Medical Corporation

    SC 13G - Journey Medical Corp (0001867066) (Subject)

    11/29/24 2:00:25 PM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Leadership Updates

    Live Leadership Updates

    View All

    BitFuFu to Update Investors at the Emerging Growth Conference on December 11, 2025

    SINGAPORE, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced that it will provide a brief update to investors at the Emerging Growth Conference on December 11, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Vice President of Investor Relations, Charley Brady, who will present an update and, time permitting, open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event. BitFuFu will be presenti

    12/9/25 11:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

    ORLANDO, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (the "Company") is pleased to announce that it has been invited to present on the Emerging Growth Conference on August 20, 2025. The next Emerging Growth Conference is presenting on August 20, 2025. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's Chairman, Serguei Melnik in real time. Mr. Melnik will perform a presentation and may subsequently open the floor for questions. Please submit your questions in advance to [email protected] or ask your questions during the event and Mr. Melnik will do his best to

    8/18/25 9:00:00 AM ET
    $NTRB
    Industrial Specialties
    Health Care